The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
8648606 |
72 |
Use of a dipeptide chemical library in the development of non-peptide tachykinin NK3 receptor selective antagonists. |
Cambridge University Forvie Site |
8691422 |
25 |
2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor. |
Smithkline Beecham |
| 22 |
The development of a novel series of non-peptide tachykinin NK3 receptor selective antagonists |
TBA |
| 24 |
The rational development of small molecule tachykinin NK3 receptor selective antagonists - the utilisation of a dipeptide chemical library in drug design |
TBA |
19817444 |
45 |
Identification of a critical residue in the transmembrane domain 2 of tachykinin neurokinin 3 receptor affecting the dissociation kinetics and antagonism mode of osanetant (SR 142801) and piperidine-based structures. |
F. Hoffmann-La Roche |
| 41 |
Identification and chemical synthesis of MDL 105,212, a non-peptide tachykinin antagonist with high affinity for NK1 and NK2 receptors |
TBA |
| 8 |
The design and synthesis of non-peptide ligands with affinity and selectivity for tachykinin receptors |
TBA |
| 13 |
Alternative strategies towards the identification of chemical lead compounds by rational design |
TBA |
| 23 |
Methionine replacements in biologically active peptides |
TBA |
10937720 |
24 |
Combined tachykinin receptor antagonist: synthesis and stereochemical structure-activity relationships of novel morpholine analogues. |
Sankyo |
7562907 |
33 |
New spiropiperidines as potent and selective non-peptide tachykinin NK2 receptor antagonists. |
Glaxo Wellcome Medicines Research Centre |
1714957 |
12 |
Pseudopeptide analogues of substance P and leucine enkephalinamide containing the psi (CH2O) modification: synthesis and biological activity. |
Hebrew University of Jerusalem |
1378901 |
18 |
The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisst. |
Pfizer |